Word: labs
(lookup in dictionary)
(lookup stats)
Dates: during 1990-1999
Sort By: most recent first
(reverse)
...said the hesitance of professionals to take her seriously was not surprising. Even some of the older lab staff did not really grasp how much in-depth scientific work she had done until after the research was completed...
...belts transport blood or urine specimens in containers that resemble toy railroad cars from a collection point to a computerized analyzer. The machine takes a sample with a dipstick; the computer reads the results and flashes them to the monitor of the doctor in charge of the case. The lab will save the salaries of dozens of people who "used to move the specimens around by hand, read the test results on a screen and then telephone the doctor," says Scalzi. The lab cost $7 million to set up but is expected to save $2 million to $3 million...
When Pam, a lab research assistant at a Midwestern company, was called in for her annual review recently, her boss was sympathetic about the sharp decline in her job performance. He knew that Pam, a recovering alcoholic, had been battling manic depression and grieving over a death in her family. What he didn't know, however, was that Pam had been spending up to six hours of her workday sending e-mail to friends and playing electronic games. The consequences of Pam's compulsion extend beyond the work time lost. "Sometimes I forget where I'm at, and I might...
...stop these spiraling costs, employers joined managed-care organizations (like HMOs) and began to set their own prices for medical services. Doctors and hospitals must accept these fees or risk losing patients. Hospitals have lost money. At Duke the crisis has spread to the research lab and the medical school. People wonder if the academic medical center--the source of many important scientific breakthroughs--can survive. Meanwhile, managed-care companies, having picked up the easiest profits early on, have begun to see their own costs rise...
...cultures can be cultivated in sterile surroundings. The $1.5 million facility was paid for by the pharmaceutical giant Rhone-Poulenc Rorer, based in Collegeville, Pa. But this particular deal is unusual in that the company has no commercial claim on any products developed through the use of the new lab. Sue Strauss is one of 18 Duke patients in Lyerly's trial, one of several vaccine tests approved by the Food and Drug Administration...